Baxter International Inc. Buyback
OLI recorded this information on 2/20/2018
Company:
Baxter International Inc.
Buyback:
BAX buyback
$Amount Authorized:
$2,300,000,000
Buyback Details:
Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program. The Board of Directors of Baxter has declared a quarterly cash dividend of $0.16 per share of common stock, payable on April 2, 2018, to stockholders of record as of March 2, 2018. The indicated annual dividend rate is $0.64 per share of common stock. Baxter's Board of Directors also has approved a $1.5 billion increase in authorization for the company's existing share repurchase plan. Based on these actions, the share repurchase plan has approximately $2.3 billion of repurchase authority available as of the date hereof to make repurchases pursuant to existing Rule 10b5-1 plans or otherwise. Shares will be repurchased in the open market or through private transactions at times and amounts determined by the company based on its evaluation of market conditions and other factors.
Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products, surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices. Co. manages its global operations based on four segments, consisting of the following geographic segments: North and South America, Europe, Middle East and Africa, and Asia-Pacific, and a global segment for its Hill-Rom Holdings, Inc. business.
Baxter International SEC Filing Email Alerts Service
Open the BAX Page at The Online Investor »
|
Open the BAX Page at The Online Investor (in a new window) »
Free BAX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.67 out of 4) 12nd percentile
(ranked lower than approx. 88% of all stocks covered)
Analysts' Target Price: BAX Stock Forecast Based on Zacks ABR data; powered by Xignite |